Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis

Small molecule medications like apremilast are emerging as promising options for patients with psoriasis and other inflammatory conditions. Apremilast was approved by the Food and Drug Administration in 2014 for the management of both psoriasis and psoriatic arthritis. Apremilast inhibits phosphodie...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Jia C, Wu, Albert G, Contento, Marissa N, Maher, Jacqueline M, Cline, Abigail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921676/
https://www.ncbi.nlm.nih.gov/pubmed/35300435
http://dx.doi.org/10.2147/CCID.S266036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921676/
https://www.ncbi.nlm.nih.gov/pubmed/35300435
http://dx.doi.org/10.2147/CCID.S266036

Ejemplares similares